Protagenic Therapeutics, Inc.
PTIXNASDAQHealthcare● Active
$0.50
$-0.03(-5.66%)
Market Cap$905104
P/E Ratio—
52W High$6.2
52W Low$0.25
Protagenic Therapeutics, Inc. (PTIX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PTIX · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 9, 2026EPS Actual
-$0.47
Est. -$4.48 · +89.5%
Revenue
—
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 9, 2026
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
PTIX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | May 11, 2026 | -$4.48 | — | — | — | — | — |
| ▲ Q1 FY2026 | Mar 9, 2026 | -$4.48 | -$0.47 | +89.5% | — | — | — |
| — Q4 FY2025 | Nov 26, 2025 | — | -$0.47 | — | — | — | — |
| — Q3 FY2025 | Aug 18, 2025 | — | -$1.37 | — | — | — | — |
| — Q2 FY2025 | May 13, 2025 | — | -$2.75 | — | — | — | — |
| — Q1 FY2025 | Mar 31, 2025 | — | -$3.36 | — | — | — | — |
| — Q4 FY2024 | Nov 14, 2024 | — | -$1.96 | — | — | — | — |
| — Q3 FY2024 | Aug 14, 2024 | — | -$5.04 | — | — | — | — |
Q2 FY2026
May 11, 2026
EPS Actual
—
EPS Est.
-$4.48
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 9, 2026Beat
EPS Actual
-$0.47
EPS Est.
-$4.48
EPS Surpr.
+89.5%
Revenue
—
Q4 FY2025
Nov 26, 2025
EPS Actual
-$0.47
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 18, 2025
EPS Actual
-$1.37
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 13, 2025
EPS Actual
-$2.75
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 31, 2025
EPS Actual
-$3.36
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 14, 2024
EPS Actual
-$1.96
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 14, 2024
EPS Actual
-$5.04
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2026 | $-2.80 | $-2.80 | $-2.80 | 1 |
| Q1 FY2026 | $-4.48 | $-4.48 | $-4.48 | 1 |
| Q4 FY2025 | $-4.48 | $-4.48 | $-4.48 | 1 |
| Q3 FY2025 | $-4.48 | $-4.48 | $-4.48 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Mar 9, 2026 | +89.5% | $0.42 | $0.42 | +0.00% |
| — Q4 FY2025 | Nov 26, 2025 | — | $2.23 | $2.23 | +0.00% |
| — Q3 FY2025 | Aug 18, 2025 | — | $2.93 | $2.78 | -5.12% |
| — Q2 FY2025 | May 13, 2025 | — | $3.06 | $3.51 | +14.71% |
| — Q1 FY2025 | Mar 31, 2025 | — | $3.15 | $2.73 | -13.33% |
| — Q4 FY2024 | Nov 14, 2024 | — | $9.10 | $9.67 | +6.26% |
| — Q3 FY2024 | Aug 14, 2024 | — | $10.00 | $8.90 | -11.00% |
| — Q2 FY2024 | May 15, 2024 | — | $17.50 | $19.46 | +11.20% |
Q1 FY2026+0.00%
Report Date
Mar 9, 2026
EPS Beat/Miss
+89.5%
Price Before
$0.42
Price After
$0.42
Q4 FY2025+0.00%
Report Date
Nov 26, 2025
EPS Beat/Miss
—
Price Before
$2.23
Price After
$2.23
Q3 FY2025-5.12%
Report Date
Aug 18, 2025
EPS Beat/Miss
—
Price Before
$2.93
Price After
$2.78
Q2 FY2025+14.71%
Report Date
May 13, 2025
EPS Beat/Miss
—
Price Before
$3.06
Price After
$3.51
Q1 FY2025-13.33%
Report Date
Mar 31, 2025
EPS Beat/Miss
—
Price Before
$3.15
Price After
$2.73
Q4 FY2024+6.26%
Report Date
Nov 14, 2024
EPS Beat/Miss
—
Price Before
$9.10
Price After
$9.67
Q3 FY2024-11.00%
Report Date
Aug 14, 2024
EPS Beat/Miss
—
Price Before
$10.00
Price After
$8.90
Q2 FY2024+11.20%
Report Date
May 15, 2024
EPS Beat/Miss
—
Price Before
$17.50
Price After
$19.46
Avg Beat Reaction+0.00%
Beat Rate1 / 8 quarters
Largest Move+14.71% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PTIX ends December
Protagenic Therapeutics, Inc. (PTIX) most recently reported earnings on March 9, 2026 for Q1 FY2026, posting EPS of $-0.47 — beating the analyst consensus of $-4.48 by +89.5%. The next PTIX earnings date is expected around September 1, 2026.
Each quarter, investors track PTIX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PTIX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PTIX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PTIX earnings · 5 questionsProtagenic Therapeutics, Inc.'s next earnings report is expected around September 1, 2026. PTIX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PTIX historically reports after market close (AMC).
PTIX earnings datewhen is PTIX earningsPTIX next earnings datewhen does PTIX report earningsPTIX earnings calendar
▸ Source: FMP · Protagenic Therapeutics, Inc. SEC filings · US GAAP · Protagenic Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026